Ładuje się......
Clinical predictors of extrapyramidal symptoms associated with aripiprazole augmentation for the treatment of late-life depression in a randomized controlled trial
OBJECTIVE: Augmentation with aripiprazole is an effective pharmacotherapy for treatment resistant late-life depression (TRLLD). However, aripirprazole can cause extrapyramidal symptoms (EPS) such as akathisia and parkinsonism; these symptoms are distressing and can contribute to treatment discontinu...
Zapisane w:
| Wydane w: | J Clin Psychiatry |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996023/ https://ncbi.nlm.nih.gov/pubmed/29924506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.17m11764 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|